A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 647
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IBC
Long Form : inflammatory breast cancer
No. Year Title Co-occurring Abbreviation
2022 Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer. IMC
2022 Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy. DFS, OS
2022 Characterization of the Immune Microenvironment in Inflammatory Breast Cancer Using Multiplex Immunofluorescence. ---
2022 Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancer. DFS, LRRFS, OS, TNBC
2022 Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. ER
2022 Contemporary surgical management of inflammatory breast cancer: a narrative review. BCS, CPM, MRM
2022 Contemporary Trends in Breast Reconstruction Use and Impact on Survival Among Women with Inflammatory Breast Cancer. SEER
2022 Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study. TN
2022 Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer. HER2, pCR
10  2022 Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118. HER2, IF, IMC, PR
11  2022 Ganoderma lucidum enhances carboplatin chemotherapy effect by inhibiting the DNA damage response pathway and stemness. DDR, GLE
12  2022 Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism. cfDNAs, MBC
13  2022 Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age. GCT, HR, MRM, NAC, OR
14  2022 HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications. IDFS, OS, pCR
15  2022 HER2-Positive Inflammatory Breast Cancer Challenges of Clinical Practices. ---
16  2022 How should radiation be done for inflammatory breast cancer patients?-a narrative review of modern literature. RT
17  2022 Inflammatory breast cancer with excellent response to pembrolizumab-chemotherapy combination: A case report. ---
18  2022 Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery? pCR
19  2022 Inflammatory Breast Cancer: The Cytokinome of Post-Mastectomy Wound Fluid Augments Proliferation, Invasion, and Stem Cell Markers. CSCs, EMT, MRM, WF
20  2022 Inflammatory Breast Cancer: The Secretome of HCMV+ Tumor-Associated Macrophages Enhances Proliferation, Invasion, Colony Formation, and Expression of Cancer Stem Cell Markers. BCSC, HCMV, TAMs
21  2022 Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. CI, EFS, OS, SCV
22  2022 Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. BCRL
23  2022 Mammographically Occult Invasive Lobular Carcinoma With Intradermal Invasion. ER, ILC, PR
24  2022 Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. DSS, MRM
25  2022 Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer. CC3, eCPMV, IMC, MPO
26  2022 Paracrine IL-6 Signaling Confers Proliferation between Heterogeneous Inflammatory Breast Cancer Sub-Clones. IL
27  2022 Proton therapy for the treatment of inflammatory breast cancer. AEs, DMFS, IMPT, OS
28  2022 Radiotherapy in the Management of Non-Metastatic Inflammatory Breast Cancers: A Retrospective Observational Study. DFS, LRRFS, non-pCR, OS, TNBC
29  2022 Role of adipose tissue-derived cytokines in the progression of inflammatory breast cancer in patients with obesity. BC, CAAT, CSC, CSC, EMT, IL-6, IL-8, MCP-1, qPCR
30  2022 Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US. ALND, OR, SLNB
31  2022 What is the best treatment recommendation for HER2+ IBC with residual disease?-a narrative review. HER2, HR, IDFS, pCR
32  2022 Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges: a narrative review. ---
33  2021 A novel CD74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report. NGS, NSCLC, PET/CT
34  2021 A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer. LABC, pCR
35  2021 Anti-Angiogenic Treatments Interact with Steroid Secretion in Inflammatory Breast Cancer Triple Negative Cell Lines. ---
36  2021 Breast Reconstruction in Inflammatory Breast Cancer: An Analysis of Predictors, Trends, and Survival from the National Cancer Database. CI
37  2021 Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients. ddPCR, LAIBC, NCT
38  2021 Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis. AJCC, BCSS, HR, non-IBC, SEER
39  2021 Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. CAM, OS
40  2021 Current Surgical Management of Inflammatory Breast Cancer. HER2
41  2021 Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. DCN
42  2021 Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer. DLI
43  2021 Estrogen Receptor beta-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer. ERalpha
44  2021 Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing Occult Inflammatory Breast Cancer and Can Predict Prognosis after Neoadjuvant Chemotherapy. BES, NAC, OS, PFS
45  2021 Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum. ssGSEA
46  2021 Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). cfDNA, HRR, IHC, NGS, TILs
47  2021 High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer. ---
48  2021 Identification of a Positive Association between Mammary Adipose Cholesterol Content and Indicators of Breast Cancer Aggressiveness in a French Population. EC, FC, HER2, TC
49  2021 Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004-2016. IBR, IPW, OS, PMRT, PSM
50  2021 Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors. ICIs, TLS, TME
51  2021 Induction of heparanase via IL-10 correlates with a high infiltration of CD163+ M2-type tumor-associated macrophages in inflammatory breast carcinomas. CTSL, HPSE, TN
52  2021 Inflammatory breast cancer appearance at presentation is associated with overall survival. OS
53  2021 Inflammatory Breast Cancer at the Extremes of Age. CI, HR, OS, pCR, TNBC
54  2021 Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. LCN2
55  2021 Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME). CI, OS, PFS
56  2021 MicroRNAs Involved in Inflammatory Breast Cancer: Oncogene and Tumor Suppressors with Possible Targets. ---
57  2021 Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells. ---
58  2021 MRI Changes in Breast Skin Following Preoperative Therapy for Patients with Inflammatory Breast Cancer. LRR, MRI, PST
59  2021 Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer. DFS, NACT, NLR and PLR, OS, pCR
60  2021 New Treatment Strategies for the Inflammatory Breast Cancer. ---
61  2021 Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis. C-index, CIF, ER, LNR, OCSD, PR, SEER
62  2021 Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review. CI, HSCS, pCR
63  2021 Prediction of Inflammatory Breast Cancer Survival Outcomes Using Computed Tomography-Based Texture Analysis. CT, HR, MPP, OS
64  2021 Progress for Immunotherapy in Inflammatory Breast Cancer and Emerging Barriers to Therapeutic Efficacy. ---
65  2021 Prolonged Survival in Patients with Metastatic HER2-Positive Inflammatory Breast Cancer: A Case Report and Review of the Literature. ---
66  2021 Pruritic breast mass with palpable lymph nodes in a male patient: a case report. CT, PCM
67  2021 Recent advances in the epidemiology of inflammatory breast cancer. ---
68  2021 Risk factors and prognostic factors for inflammatory breast cancer with bone metastasis: A population-based study. BM, CSS, OS, SEER, TNBC
69  2021 Robust inflammatory breast cancer gene signature using nonparametric random forest analysis. IL
70  2021 Salubrinal Exposes Anticancer Properties in Inflammatory Breast Cancer Cells by Manipulating the Endoplasmic Reticulum Stress Pathway. ATF4, CHOP, ER, HMEC, OCIF, OPG, PDI, PERK, PLA, RANKL, UPR, XBP1
71  2021 Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment. FNR, IR, pCR, SLNB
72  2021 Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer. AUC, miRNAs, PEG, qPCR, ROC, sEVs
73  2021 Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors. LCN2, siRNAs
74  2021 Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment. BC, CI, DDFS, IDFS, non-IBC, OS, pCR, SNB
75  2021 The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. BC, NACT, nIBC, RD, sTIL
76  2021 The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. CI, MRM, OS
77  2021 Trends, survival outcomes, and predictors of nonadherence to mastectomy guidelines for nonmetastatic inflammatory breast cancer. BCS, MRM, NCDB, OS
78  2021 Ultrastructural Analysis of Inflammatory Breast Cancer Cell Clusters in an Ex Vivo Environment Mechanically Mimicking the Lymph Vascular System. TEM
79  2021 Update on systemic treatment for newly diagnosed inflammatory breast cancer. pCR
80  2021 What is the best systemic treatment for newly diagnosed inflammatory breast cancer?-a narrative review. ---
81  2021 Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer. ITH
82  2021 Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers. ICGC, PCAWG, SNVs, WGS
83  2020 A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer. DFS, NLR, PLR, RFS
84  2020 A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer. CI, HR, non-IBC, SEER, TNBC
85  2020 Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer. OS
86  2020 Biological subtype, treatment response and outcomes in inflammatory breast cancer using data from the National Cancer Database. NCDB, pCR
87  2020 Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility. TME
88  2020 Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program. BMI
89  2020 Combining primary cohort data with external aggregate information without assuming comparability. CER
90  2020 Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning. CECT
91  2020 Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives. BC
92  2020 ERBB4 promotes the progression of inflammatory breast cancer through regulating PDGFRA. IHC, PDGFRA, RT-PCR
93  2020 Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients. LN, NACT, OS
94  2020 Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery? CI, HER2, HR, MRM, NAC, OR
95  2020 Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer. NGS, TN
96  2020 Hemoglobin overexpression and splice signature as new features of inflammatory breast cancer? ---
97  2020 Identification of Potential Key Genes and Pathways for Inflammatory Breast Cancer Based on GEO and TCGA Databases. DEGs, GEO, GO, KEGG, PPI
98  2020 IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2. CTSB, IL-8, TAMs, TN
99  2020 Immune phenotype of patients with stage IV metastatic inflammatory breast cancer. TN
100  2020 In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer. ECM